Recombinant human insulin-like growth factor-I in ALS: Description of a double-blind, placebo-controlled study

D. J. Lange, K. J. Felice, B. W. Festoff, M. J. Gawel, D. F. Gelinas, R. Kratz, E. C. Lai, M. F. Murphy, H. M. Natter, F. H. Norris, S. Rudnicki

Research output: Contribution to journalArticlepeer-review

50 Scopus citations

Fingerprint

Dive into the research topics of 'Recombinant human insulin-like growth factor-I in ALS: Description of a double-blind, placebo-controlled study'. Together they form a unique fingerprint.